These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7330967)

  • 1. Biochemical comparison of mutant H-2Kkvl (C3HfB/HeN) and parent H-2Kk (C3H/HeN) glycoproteins.
    Callahan GN; Walker LE; Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1787-91. PubMed ID: 7330967
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical comparison of MHC antigens isolated from mutant C3HfB/HeN and parent C3H/HeN mice.
    Callahan GN; Martin WJ; Pardi D
    J Immunol; 1982 May; 128(5):2116-20. PubMed ID: 7061856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical comparison of H-2K antigen isolated from C3HfB/HeN and C3H/HeN mice.
    Callahan GN; Walker LE; Martin WJ
    Immunogenetics; 1981 Mar; 12(5-6):561-8. PubMed ID: 6783513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of a defect in the H-2 genes of SV40 transformed C3H fibroblasts that do not express H-2Kk.
    Rogers MJ; Gooding LR; Margulies DH; Evans GA
    J Immunol; 1983 May; 130(5):2418-22. PubMed ID: 6300246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic complexity of H-2 antigens.
    Démant P; Iványi D; Oudshoorn-Snoek M
    Transplant Proc; 1981 Dec; 13(4):1755-8. PubMed ID: 7330964
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity.
    Vogel JM; Davis AC; McKinney DM; McMillan M; Martin WJ; Goodenow RS
    J Exp Med; 1988 Nov; 168(5):1781-800. PubMed ID: 2903213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k origin.
    Rogers MJ; Carbone G; Ballinari D; Cattaneo M; Parmiani G
    Transplant Proc; 1981 Dec; 13(4):1774-81. PubMed ID: 7330966
    [No Abstract]   [Full Text] [Related]  

  • 8. Alien H-2 antigens (H-2k) appearing on a methylcholanthrene-induced tumor (H-2d): biochemical characterization.
    Rogers MJ; Pierotti MA; Parmiani G; Appella E
    Transplant Proc; 1980 Mar; 12(1):38-45. PubMed ID: 7368292
    [No Abstract]   [Full Text] [Related]  

  • 9. The structural-genetic relationships of the H-2K and H-2D products of the mouse major histocompatibility complex.
    Nathenson SG; Ewenstein BM; Brown JL; Nisizawa T; Uehara H; Sears DW
    Birth Defects Orig Artic Ser; 1978; 14(2):217-33. PubMed ID: 76485
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary structure of murine H-2Kb and beta 2-microglobulin.
    Coligan JE; Gates FT; Kindt TJ; Ewenstein BM; Martinko JM; Uehara H; Nathenson SG
    Transplant Proc; 1981 Dec; 13(4):1792-6. PubMed ID: 6173945
    [No Abstract]   [Full Text] [Related]  

  • 11. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen.
    Iwakura Y; Itagaki K; Ishitsuka C; Yamasaki Y; Matsuzawa A; Yonehara S; Karasawa S; Ueda S; Saijo S
    J Immunol; 1998 Dec; 161(12):6592-8. PubMed ID: 9862686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of only one H-2D/L-related glycoprotein in H-2dm1 mutant cells.
    Hunt P; Burnside SS; Sears DW
    J Immunogenet; 1985 Feb; 12(1):33-44. PubMed ID: 2413133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histocompatibility difference between C3HfeB/HeN and C3H/HeN mice: tumour induced in C3HfeB/HeN mice expresses C3H/HeN-associated alloantigen.
    Martin WJ; Gipson TG; Conliffe MA; Cotton WG; Dove LF; Rice JM
    J Immunogenet; 1978 Aug; 5(4):255-60. PubMed ID: 83342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural-genetic characterizations of the murine Ss-Slp proteins.
    Parker KL; Roos MH; Shreffler DC
    Immunobiology; 1980; 158(1-2):67-71. PubMed ID: 7203524
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of a defective H-2 histocompatibility antigen by mutant mouse strain BALB/c-H-2dm2.
    Robinson PJ
    Immunogenetics; 1982; 15(4):333-40. PubMed ID: 7076287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in expression of glycoproteins by a murine fibrosarcoma detected with Staphylococcus aureus.
    Callahan GN; Pellegrino MA; Walker LE
    Transplant Proc; 1980 Mar; 12(1):87-90. PubMed ID: 7368295
    [No Abstract]   [Full Text] [Related]  

  • 19. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of H-2L alloantigens. I. Complete tryptic peptide map analysis of H-2L.
    Sears DW; Young S; Wilson PH; Christiaansen JE
    J Immunol; 1980 Jun; 124(6):2641-9. PubMed ID: 6768799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.